The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.
about
Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and ManagementManaging Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency SettingInvestigational drugs for treating agitation in persons with dementia.Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents.Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyPsychiatric and medical management of marijuana intoxication in the emergency departmentPrescribing preferences in rapid tranquillisation: a survey in Belgian psychiatrists and emergency physicians.Emergency Psychiatry: Clinical and Training Approaches.The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries.A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophreniaState of Acute Agitation at Psychiatric Emergencies in Europe: The STAGE Study.Can we predict agitation in patients with suicide attempts in the emergency department?Alternative delivery systems for agents to treat acute agitation: progress to date.The psychopharmacology of violence: making sensible decisions.Assessment and management of agitation in psychiatry: Expert consensus.Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study.Pharmacokinetics and Safety of Single-Dose Inhaled Loxapine in Children and Adolescents.Don't Label Me: A Qualitative Study of Patients' Perceptions and Experiences of Sedation During Behavioral Emergencies in the Emergency Department.Care of Psychiatric Patients: The Challenge to Emergency PhysiciansAVP-786 for the treatment of agitation in dementia of the Alzheimer's type.Protocol for the management of psychiatric patients with psychomotor agitation.Comparison of haloperidol and midazolam in restless management of patients referred to the Emergency Department: A double-blinded, randomized clinical trial.In reply:.Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series.Clinical Case Vignettes: A Promising Tool to Assess Competence in the Management of Agitation.Duboisia ingestion: An unusual cause of anticholinergic poisoning.Ketamine for the Acute Management of Excited Delirium and Agitation in the Prehospital Setting.Knowledge and Attitude Towards Pharmacological Management of Acute Agitation: A Survey of Psychiatrists, Psychiatry Residents, and Psychiatric Nurses.'Rapid tranquillisation': an historical perspective on its emergence in the context of the development of antipsychotic medications.Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial.Simulation-Based Training for Residents in the Management of Acute Agitation: A Cluster Randomized Controlled Trial.Safety and effectiveness of rapid-acting intra-muscular olanzapine for agitation associated with schizophrenia - Japan postmarketing surveillance study.Promoting Workplace Safety: Teaching Conflict Management and De-Escalation Skills in Graduate Medical Education.Comparison of Haloperidol Alone and in Combination with Midazolam for the Treatment of Acute Agitation in an Inpatient Palliative Care Service.Inhaled Loxapine for the Treatment of Psychiatric Agitation in the Prehospital Setting: A Case Series.1st International Experts' Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation.A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation
P2860
Q22252568-51965A49-1A28-4EBD-9916-E93439CCA53EQ26765899-9940F4F2-5E2D-4A29-90E4-EC8306D02B4BQ30250076-6FEEBB48-402F-4381-B501-3BC6950CE995Q34347796-4076A143-0E19-414A-8DF9-8C4D734024ACQ34652719-9E388AF9-A6AE-4CB8-86FB-287341ACD172Q34676317-795AFED3-A9E3-484D-80A6-B4799FC9882BQ35592725-476A6073-C880-4743-8AD1-2572FE776E7DQ35653131-B67A098D-1C17-40FF-AAC8-4E9D5457F0EDQ35845646-B09856AF-2887-4601-8679-7D65B60473EAQ36078953-BCD0379C-B6A5-4005-9711-219CE84B374BQ37164506-80DEB402-0AA8-415D-A2D6-8003EC4EFFDFQ37374093-61D8142B-74FC-4F26-94E2-834A881069B4Q37418358-9DAF577C-0507-4681-9602-67B1BA4A95AEQ38154852-53656C34-7E57-4297-8ABE-3F0A16204E0AQ38191300-5369C6B8-8EA2-462D-B136-5891EE1A5F11Q38749001-693D75F3-E3AE-4E05-845C-E4080BC54D73Q38761946-CB738C0F-816E-437C-9386-831E56EF841CQ38782957-4E05686A-D11C-46AD-A86D-5B8B80F886D0Q38788239-4AEE29AD-B094-47E9-8E2D-E433B34617B7Q38907833-EF01C611-A387-4D07-AB3A-0DC5A665F5F6Q39034436-E994A935-AEAA-49A2-ABD4-0451F0D5BBBFQ41467791-B83287EF-AA29-4306-82DC-B252E931E386Q41480552-60D87059-9545-45BA-B135-AD93B250490EQ42106795-99030B75-EE15-4930-8DE3-2312E7F2F655Q42697689-CD40F981-9795-49EE-833E-905621CFA4A2Q45988343-3BA22C23-5DAF-4CA1-A2E7-20F7F2F8D213Q46097030-7738B794-8118-4762-A054-0821B2E433A7Q47609442-D3D804B0-7B0B-4594-A68F-73E7FC36E44BQ47609481-86D7B128-35BA-4B80-BA53-BFD3D0DD1A93Q48084075-A1EA5E00-B52F-4136-BC1C-E88A4F6ABFEEQ48276804-83EAB779-6DBD-4838-98A2-BFEA9B2778F4Q48511740-DFCFEB83-55AE-4A2A-B51E-2441FD6BEDCDQ49318034-73FC8C7C-63BE-40A2-A564-1A3031471B3AQ50092995-AB49919E-E98C-42CD-996F-701CCD1D4AE9Q51769363-C45B1D24-7038-458E-B59B-56EF70D4802FQ55246984-D381414F-CDFE-4A6C-A556-74E79C67846BQ55294065-D7BD7508-0ACB-4431-AF77-AF446D4382DBQ56790740-33BFB7A8-A5D5-4482-B338-D839C75BB242
P2860
The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The psychopharmacology of agit ...... psychopharmacology workgroup.
@ast
The psychopharmacology of agit ...... psychopharmacology workgroup.
@en
The psychopharmacology of agit ...... psychopharmacology workgroup.
@nl
type
label
The psychopharmacology of agit ...... psychopharmacology workgroup.
@ast
The psychopharmacology of agit ...... psychopharmacology workgroup.
@en
The psychopharmacology of agit ...... psychopharmacology workgroup.
@nl
prefLabel
The psychopharmacology of agit ...... psychopharmacology workgroup.
@ast
The psychopharmacology of agit ...... psychopharmacology workgroup.
@en
The psychopharmacology of agit ...... psychopharmacology workgroup.
@nl
P2093
P2860
P1476
The psychopharmacology of agit ...... psychopharmacology workgroup.
@en
P2093
David Feifel
David Pepper
Garland H Holloman
Glenn W Currier
Michael P Wilson
P2860
P356
10.5811/WESTJEM.2011.9.6866
P577
2012-02-01T00:00:00Z